Rapid Cystic Fibrosis Mutation Screening Test

Award Information
Agency:
Department of Health and Human Services
Amount:
$2,997,640.00
Program:
SBIR
Contract:
2R44HL074607-04A2
Solitcitation Year:
2008
Solicitation Number:
PHS2007-2
Branch:
N/A
Award Year:
2008
Phase:
Phase II
Agency Tracking Number:
HL074607
Solicitation Topic Code:
N/A
Small Business Information
PHARMASEQ, INC.
PHARMASEQ, INC., 11 DEER PARK DR, STE 104, MONMOUTH JUNCTION, NJ, 08852
Hubzone Owned:
Y
Woman Owned:
Y
Socially and Economically Disadvantaged:
Y
Duns:
027661870
Principal Investigator
 WLODEK Mandecki
 (973) 972-4483
 W.MANDECKI@UMDNJ.EDU
Business Contact
 RICHARD MORRIS
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): We propose to configure a DNA-based assay to detect mutations in the gene related to cystic fibrosis (CF), encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR). The assay will have an extende

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government